(Q73520517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Wai Ming Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Wieslawa H Dragowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Marcel B Bally

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Marie Paule Schutze-Redelmeier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

3319-3329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms and therapeutic applications of immune stimulatory cpG DNA.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Immunostimulatory DNA sequences help to eradicate intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Immunostimulatory DNA sequences and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

The role of CpG in DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Sterically Stabilized Cationic Liposomes Improve the Uptake and Immunostimulatory Activity of CpG Oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Vesicles of variable sizes produced by a rapid extrusion procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Activation of skin dendritic cells by immunostimulatory DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Dendritic cell based tumor vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Liposomal delivery of CTL epitopes to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900172-5

7 January 2021

10.1016/S0264-410X(03)00172-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804863%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference